Case report of recurrent bleeding in an infant with isolated prolonged prothrombin time due to congenital factor VII deficiency---a riddle solved. [PDF]
Ganguly M+4 more
europepmc +1 more source
Effect of Latamoxef on Platelet Function and Prothrombin Time in Partially Nephrectomized Rats
Kiyohisa Uchida+4 more
openalex +1 more source
European Concerted Action on Anticoagulation (ECAA). An assessment of lyophilised plasmas for ISI calibration of CoaguChek and TAS whole blood prothrombin time monitors [PDF]
L. Poller
openalex +1 more source
Peripheral blood glypican‐3 (GPC3)‐positive circulating tumor cells (CTCs) are a risk factor for microscopic portal vein invasion and a prognostic factor in Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma (HCC). Combining the number of GPC3‐positive CTCs with the up‐to‐7 criteria enables highly accurate subclassification of BCLC ...
Yosuke Namba+15 more
wiley +1 more source
Fully printed prothrombin time sensor for point-of-care testing. [PDF]
Williams NX+6 more
europepmc +1 more source
Voriconazole potentiates warfarin‐induced prothrombin time prolongation [PDF]
Lynn Purkins+3 more
openalex +1 more source
Hepatocellular carcinoma (HCC) in the hepatitis C virus (HCV)‐sustained virologic response (SVR) group was associated with alcohol consumption and metabolic diseases and showed significantly lower rates of ARID2 alterations and AXIN1 alterations compared to the HCV‐non‐SVR group, with a mutational profile resembling that of the steatotic liver disease ...
Fukiko Kawai‐Kitahata+21 more
wiley +1 more source
Impact of Lupus Anticoagulant on INR Using Recombinant Prothrombin Time Reagent. [PDF]
Kamal F, Othman HR.
europepmc +1 more source
Effect of the reaction temperature on the prothrombin time and the apparent International Normalized Ratio determined with International Standards for thromboplastins. [PDF]
Van Den Besselaar AMHP, Cobbaert CM.
europepmc +1 more source
This study demonstrates that continuous intravenous infusion of hepatocyte growth factor can significantly reduce liver fibrosis in rats. This treatment promotes hepatocyte regeneration and reduces harmful inflammation, offering promising potential as a therapy for liver cirrhosis in humans. ABSTRACT Aim Liver cirrhosis is a severe condition that often
Oki Taniyama+15 more
wiley +1 more source